Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Human Prothrombin Complex

Approval Number

国药准字S20190034

Company南岳生物制药有限公司

Registration Date

April 3, 2024

Drug Information

Generic Name

人凝血酶原复合物

Brand Name

拓咨

Dosage Form

注射剂

Strength

每瓶含人凝血因子Ⅸ200IU。

Drug Type

生物制品

Registration Date

April 3, 2024

Company Information

Applicant Company

Company Name南岳生物制药有限公司

Company Address

湖南省衡阳市雁峰区白沙洲工业园白沙工业大道28号

Manufacturing Company

Company Name南岳生物制药有限公司

Company Address

湖南省衡阳市雁峰区白沙洲工业园白沙工业大道28号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy